Endocannabinoid System & Chronic Low Back Pain: Phase 3 Trial Results on Cannabis Sativa Extracts
This phase 3 randomized controlled trial chronic low back pain study evaluated the full-spectrum cannabis extract VER-01 against placebo over 12 weeks. Results showed a modest but statistically significant pain reduction. The trial provides important…
Cannabis Sativa Extracts for Chronic Low Back Pain: A Phase 3 Randomized Trial
Clinical Takeaway A phase 3 randomized controlled trial enrolled 820 adults with chronic low back pain to evaluate VER-01, a full-spectrum cannabis extract, against placebo over a 12-week double-blind period with up to one year of follow-up. The trial…
Clinical Research on Full-Spectrum Cannabis Extract VER-01 for Back Pain
The full-spectrum cannabis extract VER-01 was evaluated in a phase 3 clinical trial for chronic low back pain. This study demonstrated meaningful pain reduction and safety over 12 weeks and extended follow-up. VER-01 offers promising evidence as a…
